Public-registry site landscape for NCT04441099, a Advanced Solid Tumor study sponsored by NBE-Therapeutics AG. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04441099 (registry record) |
| Sponsor | NBE-Therapeutics AG |
| Condition(s) | Advanced Solid Tumor; Advanced Cancer; Triple Negative Breast Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 3 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04441099 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →